Heart Failure and Cardiomyopathies

My Settings

Videos/Podcasts

My Saved Videos/Podcasts
Relevant Content
Combined Prognostic Value of Follow‐Up Ejection Fraction and Natriuretic Peptide Measurements in Heart Failure With Reduced Ejection Fraction Following Initiation of Pharmacotherapy
Journal of the American Heart Association, Ahead of Print.
Background...
Association Between Preadmission β‐Blocker Use and Venoarterial Extracorporeal Membrane Oxygenation Weaning Failure in Patients With Cardiogenic Shock
Journal of the American Heart Association, Ahead of Print.
Background...
In‐Hospital Improved Left Ventricular Ejection Fraction and Prognosis in Acute Heart Failure
Journal of the American Heart Association, Ahead of Print.
Background...
Long‐Term Efficacy and Safety of Mavacamten in Chinese Patients With Obstructive Hypertrophic Cardiomyopathy: Week 78 Results From the EXPLORER‐CN Study
Journal of the American Heart Association, Ahead of Print.
Background...
SREBP1 Transactivation of NHE3 Impairs Cardiac Contraction and Aggravates Heart Failure
Circulation, Ahead of Print.
BACKGROUND:Heart failure with reduced ej...
Sam68 Exacerbates Pathologic Cardiac Hypertrophy by Suppressing Cardiomyocyte Glucose Oxidation
Circulation, Ahead of Print.
BACKGROUND:Metabolic remodeling, marked...
Prognostic Impact of LGE Granularity Using CMR in End‑Stage Hypertrophic Cardiomyopathy
Circulation: Cardiovascular Imaging, Ahead of Print.
BACKGROUND:End-s...
LepR+ Fibroblasts in Maladaptive Cardiac Fibrosis: Mechanisms and Controversies
Circulation Research, Volume 138, Issue 11, Page e328411, May 22, 2026. Right Heart Diastology, Where Are We Now?
Circulation Research, Volume 138, Issue 11, Page e327196, May 22, 2026. Repairing the Therapeutic Framework of Mineralocorticoid Receptor Signaling in HFpEF
Circulation Research, Volume 138, Issue 11, Page e328632, May 22, 2026.